Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. (Q54737658)

3 June 2018

title

Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. (English)

1 reference

3 June 2018

0 references

Seiichi Yasuda

1

1 reference

3 June 2018

Shigeki Arii

2

1 reference

3 June 2018

Akira Mori

3

1 reference

3 June 2018

Naoki Isobe

4

1 reference

3 June 2018

Weige Yang

5

1 reference

3 June 2018

Hideaki Oe

6

1 reference

3 June 2018

Akihisa Fujimoto

7

1 reference

3 June 2018

Yoshikuni Yonenaga

8

1 reference

3 June 2018

Hiromi Sakashita

9

1 reference

3 June 2018

Masayuki Imamura

10

1 reference

3 June 2018

publication date

1 January 2004

1 reference

3 June 2018

published in

Journal of Hepatology

1 reference

3 June 2018

volume

40

1 reference

3 June 2018

page(s)

117-123

1 reference

3 June 2018

issue

1

1 reference

3 June 2018

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

1 reference

7 January 2021

Expression of vascular endothelial growth factor in human hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Determination of hexokinase isoenzyme I and II composition by RT-PCR: increased hexokinase isoenzyme II in human renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Hypoxia induces hexokinase II gene expression in human lung cell line A549.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in Wilms' tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

An immunohistochemical study of tumour vessels in metastatic liver cancers and the surrounding liver tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Mouse macrophage metalloelastase gene delivery by HVJ-cationic liposomes in experimental antiangiogenic gene therapy for murine CT-26 colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Targeting gene expression to hypoxic tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900503-8

7 January 2021

10.1016/S0168-8278(03)00503-8

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

14672622

1 reference

3 June 2018